LATEST NEWS & PUBLICATIONS
Middle East Respiratory Syndrome (MERS) virus causes severe respiratory illness and has been linked to more than 400 deaths since the illness was identified in Jordan in April, 2012. The first case outside of the Arabian Peninsula was reported in South Korea in late May; since then, 41 total cases have been traced to a cluster of Korean hospitals, and more than 1300 are in quarantine because of exposure to the virus.
A wide range of health professionals gathered in Reykjavik, Iceland, last week for the inaugural International Integrative Nursing Symposium. The three-day event was attended by about 250 people and centered around improving health care by focusing on wellbeing rather than disease. Mary Jo Kreitzer, founder and director of Consortium member The Center for Spirituality and Healing, co-chaired the conference, which focused o
The laboratory of a University of Minnesota researcher has been selected as one of 20 worldwide to receive one of the first bioprinters.
An article in the New York Times describes a worrying trend: for-profit stem cell clinics that harvest bone marrow and fat, then inject or infuse them back into patients to treat conditions as various as asthma, Parkinson's disease and aging.
The current outbreak of avian flu -- the largest in US history -- has affected more than 30 million poultry so far. An article in Science quotes Michael Osterholm, director of Consortium member center CIDRAP (Center for Infectious Disease Research and Policy), about the rapidly evolving situation.
A new study led by researchers at the University of Minnesota has found a three-way link among antibiotic use in infants, changes in the gut bacteria, and disease later in life. The imbalances in gut microbes have been tied to infectious diseases, allergies and other autoimmune disorders, and even obesity, later in life.
A startup based on research by researchers at the University of Minnesota's BioTechnology Institute, a Consortium member center, has landed its first research and development contract from a multibillion-dollar global company headquartered in Europe.